NCT02614131: A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)
- State
- Stopped early
- Phase
- Phase 1
- People
- 50 taking part
- Started
- Dec 2015
- Primary completion
- Dec 2016
- Arms
- Solanezumab (Part C)
- Results
- Posted on the registry
- 25 Nov 2015: Trial registered
- 23 Sep 2019: Trial results posted